Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,018 | -231,801 | -268,327 | -186,580 | -94,774 |
| Depreciation Amortization | -986 | 7,366 | 7,471 | 6,151 | 3,628 |
| Accounts receivable | 428 | -2,206 | -1,818 | -1,598 | -540 |
| Accounts payable and accrued liabilities | -9,796 | 3,436 | -4,628 | -7,243 | -5,007 |
| Other Working Capital | -25,776 | -16,433 | -27,751 | -23,139 | -24,535 |
| Other Operating Activity | 21,965 | -69,840 | 51,738 | 40,445 | 23,493 |
| Operating Cash Flow | $-95,183 | $-309,478 | $-243,315 | $-171,964 | $-97,735 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -249 | -3,917 | -4,768 | -4,730 | -2,804 |
| Purchase Of Investment | -128,351 | -1,030,781 | -782,218 | -607,747 | -355,916 |
| Sale Of Investment | 186,196 | 1,146,175 | 947,296 | 668,717 | 332,147 |
| Other Investing Activity | 0 | 131,784 | 0 | 0 | 0 |
| Investing Cash Flow | $57,596 | $243,261 | $160,310 | $56,240 | $-26,573 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -331 | -248 | -164 | -81 |
| Common Stock Issued | 2,467 | 2,681 | 2,576 | 1,305 | 1,289 |
| Financing Cash Flow | $2,467 | $2,350 | $2,328 | $1,141 | $1,208 |
| Beginning Cash Position | 139,259 | 203,126 | 203,126 | 203,126 | 203,126 |
| End Cash Position | 104,139 | 139,259 | 122,449 | 88,543 | 80,026 |
| Net Cash Flow | $-35,120 | $-63,867 | $-80,677 | $-114,583 | $-123,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -95,183 | -309,478 | -243,315 | -171,964 | -97,735 |
| Capital Expenditure | -399 | -4,881 | -4,768 | -4,730 | -2,804 |
| Free Cash Flow | -95,582 | -314,359 | -248,083 | -176,694 | -100,539 |